Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash & Equivalents (2021 - 2025)

Tenon Medical has reported Cash & Equivalents over the past 5 years, most recently at $3.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 42.52% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $3.8 million, down 42.52%, while the annual FY2025 figure was $3.8 million, 42.52% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $3.8 million at Tenon Medical, up from $3.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $10.3 million in Q1 2025 and troughed at $2.0 million in Q2 2024.
  • A 5-year average of $4.9 million and a median of $3.8 million in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 66.37% in 2024 and later soared 298.68% in 2025.
  • Year by year, Cash & Equivalents stood at $2.9 million in 2021, then decreased by 27.01% to $2.1 million in 2022, then increased by 14.04% to $2.4 million in 2023, then soared by 169.15% to $6.5 million in 2024, then plummeted by 42.52% to $3.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for TNON at $3.8 million in Q4 2025, $3.4 million in Q3 2025, and $7.8 million in Q2 2025.